This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oster, H. Articles by Leitges, M. Search for Related Content PubMed PubMed Citation Articles by Oster, H. Articles by Leitges, M.

Protein Kinase C but not PKC Suppresses Intestinal Tumor Formation in Apc^Min/+ Mice

¹ Laboratory for Signal Transduction, Max Planck Institute of Experimental Endocrinology and ² Department of Nephrology, Hannover Medical School, Hannover, Germany

Requests for reprints: Michael Leitges, Department of Internal Medicine/Nephrology, Hannover Medical School, Carl Neuberg Strasse Nr. 1, Hannover, Germany 30625. Phone: 49-511-5359-127; Fax: 49-511-5359-186; E-mail: michael.leitges{at}mpihan.mpg.de.

Members of the protein kinase C (PKC) family of serine/threonine kinases play key regulatory roles in numerous cellular processes, including differentiation and proliferation. Of the 11 mammalian PKC isoforms known, several have been implicated in tumor development and progression. However, in most cases, isotype specificity is poorly defined, and even contrary functions for a single PKC have been reported mostly because appropriate molecular and genetic tools were missing to specifically assess the contribution of single PKC isoforms in vivo. In this report, we therefore used PKC genetic targeting to study the role of PKC and PKC in colorectal cancer. Both isoforms were found to be strongly down-regulated in intestinal tumors of Apc^Min/+ mice. A deletion of PKC did not affect tumorigenesis in this animal model. In contrast, PKC-deficient Apc^Min/+ mice developed more aggressive tumors and died significantly earlier than their PKC-proficient littermates. Even without an additional Apc mutation, PKC knockout mice showed an elevated tendency to develop spontaneous intestinal tumors. Transcriptional profiling revealed a role for this kinase in regulating epidermal growth factor receptor (EGFR) signaling and proposed a synergistic mechanism for EGFR/activator protein and WNT/APC pathways in mediating intestinal tumor development. (Cancer Res 2006; 66(14): 6955-63)

This article has been cited by other articles:

				S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester Cancer Res., January 1, 2008; 68(1): 64 - 72. [Abstract] [Full Text] [PDF]

				H. J. Lee, Y. Ji, S. Paul, H. Maehr, M. Uskokovic, and N. Suh Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D3 Analogue Is Mediated by Ras/Protein Kinase C{alpha} Cancer Res., December 15, 2007; 67(24): 11840 - 11847. [Abstract] [Full Text] [PDF]

				T. Fevr, S. Robine, D. Louvard, and J. Huelsken Wnt/{beta}-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells Mol. Cell. Biol., November 1, 2007; 27(21): 7551 - 7559. [Abstract] [Full Text] [PDF]

				A. Gregorieff and H. Clevers Giving APCmin tumours a SPARC Gut, October 1, 2007; 56(10): 1341 - 1343. [Full Text] [PDF]

				L. Guan, K. Song, M. A. Pysz, K. J. Curry, A. A. Hizli, D. Danielpour, A. R. Black, and J. D. Black Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells J. Biol. Chem., May 11, 2007; 282(19): 14213 - 14225. [Abstract] [Full Text] [PDF]